Patients infected with the Bundibugyo strain of Ebola have begun receiving experimental treatments in a clinical trial in the Democratic Republic of Congo, according to Bloomberg.
The trial aims to improve care for the rare viral disease, which has killed more than 500 people in the country.
First Trial of Experimental Bundibugyo Ebola Treatments Begins in Congo as Death Toll Tops 100
2026-07-06 01:59:11
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
中国央行7天期逆回购70亿元，净回笼1505亿元Next article：
股票市场 | 港股汽车股走高，零跑汽车涨5.6%
